These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34781815)

  • 1. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
    Yi D; Zhang D; He J
    Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
    Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D
    BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PITPNA-AS1 regulates UNC5B expression in papillary thyroid cancer via sponging miR-129-5p.
    Mei S; Zong H; Zhou H
    Int J Biol Markers; 2021 Mar; 36(1):10-19. PubMed ID: 33706585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
    Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X
    Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
    Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
    Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
    Huang T; Guan S; Wang C
    Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
    Liu D; Zhang M; Song Y; Yang N
    Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M
    Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
    Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
    Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
    J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs SET-binding factor 2-antisense RNA1 promotes cell growth through targeting miR-431-5p/CDK14 axis in human papillary thyroid cancer.
    Wen HL; Xu ZM; Wen D; Lin SY; Liang Y; Xie JP
    Kaohsiung J Med Sci; 2020 Oct; 36(10):808-816. PubMed ID: 32602632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
    Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
    J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
    Ding H; Cui L; Wang C
    Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
    Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
    Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via microRNA-181b-5p-Dependent Inhibition Tripartite Motif Containing 3.
    Zhao Y; Feng X; Zhao Y; Yang H; Zhang C
    Mol Biotechnol; 2023 Mar; 65(3):477-490. PubMed ID: 36030355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
    Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G
    Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.